Semisynthetic Catalytic Antibodies

  • Scott J. Pollack
  • Peter G. Schultz
Part of the New Horizons in Therapeutics book series (NHTH)


Our ability to carry out selective chemical transformations on biologically important molecules—including proteins, nucleic acids, and sugars—has been limited until recently to the specific reactions catalyzed by existing enzymes and the relatively indiscriminate reactions carried out by chemical reagents. The rational design of catalysts for the selective modification of structurally complex molecules would greatly impact on biochemistry, molecular biology, and medicine. Moreover, the synthesis and characterization of such catalysts should provide additional insight into the molecular basis for ligand-receptor recognition and catalysis. Crucial to the design of selective catalysts is the generation of highly selective binding sites. By taking advantage of the natural immune system, monoclonal antibody technology (Kohler and Milstein, 1975; Seiler et al., 1985) has made it possible to generate homogeneous ligand binding sites with enzymelike affinities and specificities. Antibodies have been selectively generated against biopolymers, such as nucleic acids, proteins, and polysaccharides, and smaller multifunctional molecules, such as steroids and prostaglandins. Antibodies bind ligands ranging in size from about 6 to 34 Å with association constants in the range of 104−1014 M−1 (Pressman and Grossberg, 1968; Goodman, 1975; Nisonoff et al., 1975). Antibody—ligand specificity is well illustrated by the following examples: antibodies generated against cis N-phenylmaleic acid monoamide bound the trans isomer with 103 lower affinity (Landsteiner and van der Scheer, 1934); antibodies against 3,17-androstenedione bound 3a, 17-dihydroxyandrostene with 103 lower affinity (Milewich et al.,1975).


Catalytic Antibody Claisen Rearrangement Affinity Label Thiol Ester Catalytic Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bruice, T. C., 1959, Imidazole catalysis. The intramolecular nucleophilic catalysis of the hydrolysis of an acyl thiol, J. Am. Chem. Soc. 81: 5444–5449.CrossRefGoogle Scholar
  2. Bruice, T. C., and Schmir, G. L., 1958, Imidazole catalysis. The reaction of substituted imidazoles with phenyl acetates in aqueous solution, J. Am. Chem. Soc. 80: 148–156.CrossRefGoogle Scholar
  3. Chan, E. Y., Crampton, R. G., and Clapp, L. B., 1979, Benzothiazepinones, related compounds, and the Smiles rearrangement, Phosphorous Sulfur 7: 41–45.CrossRefGoogle Scholar
  4. Cochran, A., Sugasawara, R., and Schultz, P. G., 1988, Photosensitized cleavage of a thymine dimer by an antibody, J. Am. Chem. Soc. 110: 7888–7890.CrossRefGoogle Scholar
  5. Corey, D. R., and Schultz, P. G., 1987, Generation of a hybrid sequence-specific single-stranded deoxyribonuclease, Science 238: 1401–1403.PubMedCrossRefGoogle Scholar
  6. Durfor, C. N., Bolin, R. J., Sugasawara, R., Massey, R. J., Jacobs, J. W., and Schultz, P. G., 1988, Antibody catalysis in reverse micelles, J. Am. Chem. Soc. 110: 8713–8714.CrossRefGoogle Scholar
  7. Givol, D., and Wilchek, M., 1977, Affinity labeling of antibody combining sites as illustrated by anti-dinitrophenyl antibodies, Methods Enzymol. 46: 479–492.PubMedCrossRefGoogle Scholar
  8. Givol, D., Strausbauch, P. H., Hurwitz, E., Wilchek, M., Haimovich, J., and Eisen, H. N., 1971, Affinity labeling and cross-linking of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity, Biochemistry 10: 3461–3466.PubMedCrossRefGoogle Scholar
  9. Goetzl, E. J., and Metzger, H., 1970, Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands, Biochemistry 9: 1267–1278.PubMedCrossRefGoogle Scholar
  10. Goodman, J. W., 1975, in: The Antigens(M. Sela, ed.), Academic Press, New York, pp. 127–187.Google Scholar
  11. Grassetti, D. R., and Murray, J. S., 1967, Determination of sulfhydryl groups with 2,2’- or 4,4’dithiodipyridine, Arch. Biochem. Biophys. 119: 41–49.PubMedCrossRefGoogle Scholar
  12. Haimovich, J., Eisen, H. N., Hurwitz, E., and Givol, D., 1972, Localization of affinity-labeled residues on the heavy and light chain of two myeloma proteins with anti-hapten activity, Biochemistry 11: 2389–2398.PubMedCrossRefGoogle Scholar
  13. Haselkorn, D., Friedman, S., Givol, D., and Pecht, I., 1974, Kinetic mapping of the antibody combining site by chemical relaxation spectrometry, Biochemistry 13: 2210–2222.PubMedCrossRefGoogle Scholar
  14. Hilvert, D., Carpenter, S. H., Nared, K. D., and Auditor, M. M., 1988, Catalysis of concerted reactions by antibodies: The Claisen rearrangement, Proc. Natl. Acad. Sci. U.S.A. 85: 4953–4955.PubMedCrossRefGoogle Scholar
  15. Holbrook, J. J., and Ingram, V. A., 1973, Ionic properties of an essential histidine residue in pig heart lactate dehydrogenase, Biochem. J. 131: 729–738.PubMedGoogle Scholar
  16. Jackson, D. Y., Jacobs, J. W., Sugasawara, R., Reich, S. H., Bartlett, P. A., and Schultz, P. G., 1988, An antibody-catalyzed Claisen rearrangement, J. Am. Chem. Soc. 110: 4841–4842.CrossRefGoogle Scholar
  17. Jacobs, J. W., Schultz, P. G., Sugasawara, R., and Powell, M., 1987, Catalytic antibodies, J. Am. Chem. Soc. 109: 2174–2176.CrossRefGoogle Scholar
  18. Janda, K. D., Lerner, R. A., and Tramontano, A., 1988, Antibody catalysis of bimolecular amide formation, J. Am. Chem. Soc. 110: 4835–4837.CrossRefGoogle Scholar
  19. Kaiser, E. T., and Lawrence, D. S., 1984, Chemical mutation of enzyme active sites, Science 226: 505–511.PubMedCrossRefGoogle Scholar
  20. Kohler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256: 495–497.PubMedCrossRefGoogle Scholar
  21. Landsteiner, K., and van der Scheer, J., 1934, Serological studies on azoproteins, J. Exp. Med. 59: 751–768.PubMedCrossRefGoogle Scholar
  22. Milewich, L., Sanchez, C. G., MacDonald, P. C., and Siiteri, P. K., 1975, Radioimmunoassay of androstenedione: The steroid molecule as a probe for antibody specificity, J. Steroid Biochem. 6: 1381–1387.PubMedCrossRefGoogle Scholar
  23. Napper, A. D., Benkovic, S. J., Tramontano, A., and Lerner, R. A., 1987, A stereospecific cyclization catalyzed by an antibody, Science 237: 1041–1043.PubMedCrossRefGoogle Scholar
  24. Nisonoff, A., Hopper, J., and Spring, S., 1975, The Antibody Molecule, Academic Press, New York.Google Scholar
  25. Pollack, S. J., and Schultz, P. G., 1987, Antibody catalysis by transition state stabilization, Cold Spring Harbor Symp. Quant. Biol. 52: 97–104.PubMedCrossRefGoogle Scholar
  26. Pollack, S. J., and Schultz, P. G., 1989, A semisynthetic catalytic antibody, J. Am. Chem. Soc. 111: 1929–1931.CrossRefGoogle Scholar
  27. Pollack, S. J., Jacobs, J. W., and Schultz, P. G., 1986, Selective chemical catalysis by an antibody, Science 234: 1570–1573.PubMedCrossRefGoogle Scholar
  28. Pollack, S. J., Nakayama, G. R., and Schultz, P. G., 1988, Introduction of nucleophiles and spectroscopic probes into antibody combining sites, Science 242: 1038–1041.PubMedCrossRefGoogle Scholar
  29. Pressman, D., and Grossberg, A., 1968, The Structural Basis of Antibody Specificity, Benjamin, New York.Google Scholar
  30. Raso, V., and Stollar, B. D., 1975, The antibody—enzyme analogy. Characterization of antibodies to phosphopyridoxyltyrosine derivatives, Biochemistry 14: 584–591.PubMedCrossRefGoogle Scholar
  31. Seiler, F. R., Gronski, P., Kurrle, R., Luben, G., Harthus, H., Ax, W., Bosslet, K., and Schwick, H., 1985, Monoclonal antibodies: their chemistry, functions, and possible uses, Angew. Chem. Int. Ed. Engl. 24: 139–226.CrossRefGoogle Scholar
  32. Shokat, K. M., Leumann, C. H., Sugasawara, R., and Schultz, P. G., 1988, An antibody-mediated redox reaction, Angew. Chem. Int. Ed. Eng. 27: 1172–1174.CrossRefGoogle Scholar
  33. Strausbauch, P. H., Weinstein, Y., Wilchek, M., Shaltiel, S., and Givol, D., 1971, A homologous series of affinity labeling reagents and their use in the study of antibody binding sites, Biochemistry 10: 4342–4348.PubMedCrossRefGoogle Scholar
  34. Street, J. P., Skorey, K. I., Brown, R. S., and Ball, R. G., 1985, Biomimetic models for cysteine proteases, J. Am. Chem. Soc. 107: 7669–7679.CrossRefGoogle Scholar
  35. Tramontano, A., Janda, K. D., and Lerner, R. A., 1986, Catalytic antibodies, Science 234: 1566–1570.PubMedCrossRefGoogle Scholar
  36. Zuckermann, R. N., Corey, D. R., and Schultz, P. G., 1987, Efficient methods for attachment of thiol specific probes to the 3’-ends of synthetic oligodeoxyribonucleotides, Nucleic Acids Res. 15: 5305–5321.PubMedCrossRefGoogle Scholar
  37. Zuckermann, R. N., Corey, D. R., and Schultz, P. G., 1988, Site-selective cleavage of RNA by a hybrid enzyme, J. Am. Chem. Soc. 110: 1614–1615.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Scott J. Pollack
    • 1
  • Peter G. Schultz
    • 1
  1. 1.Department of ChemistryUniversity of CaliforniaBerkeleyUSA

Personalised recommendations